Abstract
We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator shocks.
MeSH terms
-
Acute Disease
-
Cardiovascular Agents / therapeutic use
-
Catheter Ablation
-
Clinical Trials as Topic
-
Defibrillators, Implantable / adverse effects*
-
Defibrillators, Implantable / standards
-
Electric Countershock / adverse effects*
-
Electric Countershock / instrumentation*
-
Electric Countershock / methods
-
Electrocardiography
-
Equipment Failure Analysis
-
Heart Failure / complications
-
Heart Failure / physiopathology
-
Heart Failure / therapy*
-
Humans
-
Intra-Aortic Balloon Pumping
-
Patient Selection
-
Severity of Illness Index
-
Sympathetic Nervous System / drug effects
-
Sympathetic Nervous System / physiopathology
-
Sympathetic Nervous System / surgery
-
Tachycardia, Ventricular / complications
-
Tachycardia, Ventricular / diagnosis
-
Tachycardia, Ventricular / physiopathology
-
Tachycardia, Ventricular / therapy*